Glenmark Pharma may touch Rs 1100: Vijay Chopra

Vijay Chopra of enochventures.com told CNBC-TV18, "Pharma as a sector has been hammered last year and there might be certain surprises this year as well but the way markets are, it is better to be in defensives rather than being very aggressive and going overboard and buying. So I would suggest that one can stick around with Glenmark Pharma."He further added, "It has been consistently moving. My target for the stock is about Rs 1,100 if one holds on to it with a longer-term perspective and provided there is no unknown stuff, which comes out, USFDA comes again with some kind of news. So if this doesn’t happen, I think that the stock is clearly headed for Rs 1,100. So one can hold on to the stock."